Study of ovarian reserve parameters in infertile women of different age groups

Umakant Valvekar, Santhana Lakshmi, Amar Nagesh Kumar


Background: Main causes of infertility include diminished ovarian reserve. Diminished ovarian reserve is about availability of number of good quality pre ovulatory oocytes in the ovaries. As a woman ages, her ovarian reserve decreases. In recent years assessment of “ovarian reserve” became a strategy in treatment of female infertility. Although the true and functional ovarian reserves reflect different stages of follicular development, they are inherently linked and both decline in parallel with increasing age.  Accurate measurement of the ovarian reserve has long been a quest in reproductive medicine. The objective of the study was to find out the ovarian reserve and also to correlate the ovarian reserve indicators with different age groups of infertile women.

Methods: This prospective study was conducted at Karpaga Vinayaga Institute of Medical Sciences, Madhurantagam, Chennai, Tamilnadu, India during the period of January 2014 to April 2016. The study comprises of 100 newly diagnosed PCOS women and they were all divided into three age groups. Group I consists of infertile women who were under the age of 26 years or less than 26 years. Group II consists of infertile women of age range between 27 to 35 years. Group III consists of infertile women who are 36 years and greater than 36 years of age.

Results: In the present study, ovarian reserve markers had shown significant variation with age in infertile women. Of the markers considered, progesterone, anti-mullerian hormone (AMH) and antral follicle count (AFC) exhibited significant correlation with age. Luteinizing hormone (LH), follicle-stimulating hormone (FSH) with AFC did not show any significant association with age compared to AMH, progesterone and AFC.

Conclusions: Our study results also indicate that serum AMH measurement is better predictor for the number of early antral follicles than conventional hormone measurements. Using AMH measurement in combination with AFC may improve the assessment of ovarian reserve for evaluating the fertility potential and monitoring infertility treatment.


Infertility, Ovarian reserve, Antiullerian hormone, Antral follicle count, Progesterone

Full Text:



Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. Public Lib Sci one. 2010;5:8772.

Yong PTK, Baird DT, Thong KJ. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod. 2003;18:35-44.

Welt CK, Mcnicholl DJ, Taylor AE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab. 1999;84:105-12.

Testing and interpreting measures of ovarian reserve: a committee opinion. Practice committee of the american society for reproductive medicine. Fertil Steril. 2012;98:1407-15.

The rotterdam ESHRE/ASRM-sponsored consensus workshop group revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19:41-7.

Lamarca A, Volpe A. Anti-mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool. Clin Endocrinol. 2006;64(6):603-10.

Nelson SM, Messow MC, Wallace AM, Fleming R, Mcconnachie A. Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients. Fertil Steril. 2011;95(2):736-41.

Van DJ, Faddy MJ, Themmen APN, Jong FH, Peeters PHM, Schouw YT, et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clinical Endocrinol Metab. 2008;93(6):2129-34.

Vet A, Laven JS, Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357-62.

Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clinical Endocrinol Metab. 1999;84(11):4025-30.

Feyereisen E, Mendez LDH, Taieb J, Hesters L, Frydman R, Fanchin R. Anti-mullerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online. 2006;12(6):695-703.

Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18(2):323-27.

Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in-vitro fertilization cycles. Fertil Steril. 2003;80(2):350-5.

Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, et al. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-mullerian hormone and response to controlled ovarian stimulation. Fertil Steril. 2010;94(5):1775-81.

Weenen C, Laven JS, Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77-83.

Goksedef BP, Idis N, Gorgen H, Asma YR, Api M, Çetin A. The correlation of the antral follicle count and serum anti-mullerian hormone. J Turkish-German Gynecol Assoc. 2010;11:212-5.

Eilertsen TB, Vanky E, Carlsen SM. Anti-mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod. 2012;27(8):2494-502.

Rosenfield RL, Wroblewski K, Padmanabhan V, Littlejohn E, Mortensen M, Ehrmann DA. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012;98(1):242-9.

Belosi C, Selvaggi L, Apa R, Guido M, Romualdi D, Fulghesu AM, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod. 2006;21(12):3108-15.

Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril. 2001;76(2):326-31.